Bmj Usa

Mumps outbreak among young adults in UK

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7508.E363 (Published 07 July 2005) Cite this as: BMJ 2005;331:E363
  1. Sharon Bloom, medical officer (sbloom@cdc.gov),
  2. Melinda Wharton, acting deputy director
  1. National Immunization Program MS E-61 CDC, Atlanta, GA
  2. National Immunization Program MS E-61 CDC, Atlanta, GA

    Is the US at risk?

    The clinical review by Gupta and colleagues in this issue (p 293) is a timely reminder to clinicians who may have little experience with mumps infection and its complications. Following the United Kingdom's 1988 introduction of routine infant measles-mumps-rubella (MMR) vaccination, and the addition of a second routine dose of MMR vaccine in 1996, mumps became a rare disease in the UK, with a few hundred reports of mumps annually during the 1990s. Reported mumps cases in England and Wales increased to about 4000 in 2003, however, and to over 16 000 reported cases in 2004 (31.1 cases per 100 000 population).1 Cases have continued to be reported in 2005, predominantly among young adults aged 19 to 23 who were too old to have received two doses of MMR vaccine in the national vaccination program.1

    Is the US at risk for such an outbreak?

    The US was one of the first countries to start using the live attenuated mumps vaccine in 1967; mumps vaccine was recommended as a routine childhood vaccine …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe